Last reviewed · How we verify
NCT06058364
Effect of a Nutritional Supplement on Mental Wellness in Adults
NA trial testing Intervention 1 - Triglyceride in Low Mood in 150 participants. Completed in 8 October 2024.
24 May 2024
Quick facts
| Lead sponsor | Pharmavite LLC |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | other |
| Enrollment | 150 |
| Start date | 18 September 2023 |
| Primary completion | 24 May 2024 |
| Estimated completion | 8 October 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Intervention 1 - Triglyceride
- Intervention 2 - Placebo
Conditions studied
- Low Mood — all drugs for Low Mood →
Sponsor
Pharmavite LLC — full company profile →
Who can join
Adults 18 to 65, any sex, with Low Mood. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Trillions of microbes reside in human gut and constitute "gut microbiota". Composition of these microbes and substances produced by them play an important role in human health and wellness. The goal of this study is to determine if a unique orally consumed triglyceride supplement will impart mood benefits. Investigators hypothesize that a part of the fatty acids will be released in upper gastrointestinal (GI) tract and can be absorbed and reach different organs via systemic circulation (blood), including to the brain, and provide health benefits. Rest of the portion would reach the colon and may modulate gut microbiota and provide health benefits via the gut-brain axis (a bi-directional communication between emotional and cognitive centers and the gastrointestinal system). These health benefits could include alleviation of stress, occasional anxiousness and low mood. Participants with self-reported low mood will be randomized to two groups - one group will receive triglyceride supplement in softgel form and another group will receive a placebo (softgel with no active substance). Investigators will evaluate the effect of consumption of triglyceride supplement compared to Placebo on occasional low mood, occasional anxiousness, stress, sleep and general health by measuring changes from baseline.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Predispose, precipitate, perpetuate, and protect: how diet and the gut influence mental health in emerging adulthood.
Warren M, O'Connor C, Lee JE, Burton J, et al · · 2024 · cited 5× · PMID 38505265 · DOI 10.3389/fnut.2024.1339269
Verify or expand the search:
- PubMed search for NCT06058364
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Pharmavite LLC trials
Trials by the same sponsor.
- NCT06935123 — Impact of Nutritional Supplementation on Sleep Quality · Phase 1 · completed
- NCT06837246 — A Clinical Trial to Assess Cognitive Effects of Cognitive Nutritional Supplement in General Population · NA · recruiting
- NCT06611215 — Effect of a Nutritional Supplement on Gut Microbiota in Adults · NA · not yet recruiting
- NCT04067791 — A Study to Investigate the Pharmacokinetics of Prolonged-release Melatonin Compared to Standard, Immediate-release Melat · Phase 1 · completed
- NCT04516304 — A Nutritional Supplement on Vasomotor Symptoms in Women · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06058364 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Pharmavite LLC
- Last refreshed: 7 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06058364.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing